BRPI0815562A2 - Soluções farmacêuticas orais contendo telbivudina. - Google Patents

Soluções farmacêuticas orais contendo telbivudina.

Info

Publication number: BRPI0815562A2
Authority: BR; Brazil
Prior art keywords: telbivudine; solutions containing; oral pharmaceutical; pharmaceutical solutions; oral
Prior art date: 2007-07-12

Application number

BRPI0815562-3A2A

Other languages

English (en)

Inventor

Nabila Sekkat

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-07-12

Filing date

2008-07-10

Publication date

2015-02-18

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38724394&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0815562(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-07-10 Application filed by Novartis Ag filed Critical Novartis Ag

2015-02-18 Publication of BRPI0815562A2 publication Critical patent/BRPI0815562A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Engineering & Computer Science (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BRPI0815562-3A2A 2007-07-12 2008-07-10 Soluções farmacêuticas orais contendo telbivudina. BRPI0815562A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP07112381		2007-07-12
PCT/EP2008/059016 WO2009007426A1 (en)	2007-07-12	2008-07-10	Oral pharmaceutical solutions containing telbivudine

Publications (1)

Publication Number	Publication Date
BRPI0815562A2 true BRPI0815562A2 (pt)	2015-02-18

Family

ID=38724394

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0815562-3A2A BRPI0815562A2 (pt)	2007-07-12	2008-07-10	Soluções farmacêuticas orais contendo telbivudina.

Country Status (22)

Country	Link
US (1)	US8445457B2 (pt)
EP (1)	EP2178503A1 (pt)
JP (1)	JP5314014B2 (pt)
KR (3)	KR20100029829A (pt)
CN (1)	CN101686938B (pt)
AR (1)	AR067630A1 (pt)
AU (1)	AU2008274170B2 (pt)
BR (1)	BRPI0815562A2 (pt)
CA (1)	CA2693609A1 (pt)
CL (1)	CL2008002025A1 (pt)
CO (1)	CO6270204A2 (pt)
EC (1)	ECSP109871A (pt)
IL (1)	IL202961A (pt)
MA (1)	MA31507B1 (pt)
MY (1)	MY147366A (pt)
NZ (1)	NZ582443A (pt)
PE (2)	PE20090476A1 (pt)
RU (1)	RU2493826C2 (pt)
TN (1)	TN2010000008A1 (pt)
TW (1)	TW200911302A (pt)
WO (1)	WO2009007426A1 (pt)
ZA (1)	ZA200908993B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SMT201700035T1 (it)	2011-05-13	2017-03-08	Array Biopharma Inc	Composti di pirrolidinil urea, pirrolidinil tiourea e pirrolidinil guanidina come inibitori di chinasi trka
WO2014059363A1 (en) *	2012-10-11	2014-04-17	Antrim Pharmaceuticals Llc	Oral solution formulations of aripiprazole
SMT201900522T1 (it)	2014-05-15	2019-11-13	Array Biopharma Inc	1-((3s,4r)-4-(3-fluorofenil)-1-(2-metossietil)pirrolidin-3-il)-3-( 4-metil-3-(2- metilpirimidin-5-il)-1-fenil-1h-pirazol-5-il )urea come inibitore della trka chinasi
CN107708705A (zh) *	2015-04-26	2018-02-16	林承叡	改善肾脏病患者的肾脏功能和/或心脏功能的方法
CN107550866A (zh) *	2016-06-30	2018-01-09	康普药业股份有限公司	一种替比夫定制剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5856364A (en)	1991-03-01	1999-01-05	Warner Lambert Company	Therapeutic antiviral-wound healing compositions and methods for preparing and using same
EP1023899A1 (en)	1997-09-26	2000-08-02	Wakamoto Pharmaceutical Co., Ltd.	Aqueous preparation containing antiviral agent having purine or pyrimidine skeleton
DE19817265A1 (de)	1998-04-18	1999-10-21	Bayer Ag	Verwendung von Dihydropyrimidinen als Arzneimittel und neue Stoffe
DE19817264A1 (de)	1998-04-18	1999-10-21	Bayer Ag	Neue Dihydropyrimidine
PE20030545A1 (es)	2001-10-31	2003-06-19	Schering Corp	Formulaciones de jarabe de ribavirina
TWI244393B (en)	2002-08-06	2005-12-01	Idenix Pharmaceuticals Inc	Crystalline and amorphous forms of beta-L-2'-deoxythymidine
US20090156545A1 (en)	2005-04-01	2009-06-18	Hostetler Karl Y	Substituted Phosphate Esters of Nucleoside Phosphonates

2008
- 2008-07-10 RU RU2010104395/15A patent/RU2493826C2/ru not_active IP Right Cessation
- 2008-07-10 KR KR1020107000530A patent/KR20100029829A/ko not_active Ceased
- 2008-07-10 CN CN2008800241250A patent/CN101686938B/zh active Active
- 2008-07-10 PE PE2008001158A patent/PE20090476A1/es not_active Application Discontinuation
- 2008-07-10 CA CA2693609A patent/CA2693609A1/en not_active Abandoned
- 2008-07-10 MY MYPI20095510A patent/MY147366A/en unknown
- 2008-07-10 NZ NZ582443A patent/NZ582443A/en not_active IP Right Cessation
- 2008-07-10 US US12/667,975 patent/US8445457B2/en not_active Expired - Fee Related
- 2008-07-10 AR ARP080102959A patent/AR067630A1/es unknown
- 2008-07-10 WO PCT/EP2008/059016 patent/WO2009007426A1/en active Application Filing
- 2008-07-10 JP JP2010515512A patent/JP5314014B2/ja not_active Expired - Fee Related
- 2008-07-10 EP EP08774979A patent/EP2178503A1/en not_active Withdrawn
- 2008-07-10 BR BRPI0815562-3A2A patent/BRPI0815562A2/pt not_active IP Right Cessation
- 2008-07-10 AU AU2008274170A patent/AU2008274170B2/en not_active Ceased
- 2008-07-10 KR KR1020147002720A patent/KR20140019040A/ko not_active Ceased
- 2008-07-10 KR KR1020127016214A patent/KR20120078754A/ko not_active Withdrawn
- 2008-07-10 PE PE2012002012A patent/PE20130180A1/es not_active Application Discontinuation
- 2008-07-11 TW TW097126552A patent/TW200911302A/zh unknown
- 2008-07-11 CL CL2008002025A patent/CL2008002025A1/es unknown
2009
- 2009-12-17 ZA ZA200908993A patent/ZA200908993B/xx unknown
- 2009-12-24 IL IL202961A patent/IL202961A/en not_active IP Right Cessation
2010
- 2010-01-07 TN TNP2010000008A patent/TN2010000008A1/fr unknown
- 2010-01-07 MA MA32485A patent/MA31507B1/fr unknown
- 2010-01-12 EC EC2010009871A patent/ECSP109871A/es unknown
- 2010-01-12 CO CO10002343A patent/CO6270204A2/es active IP Right Grant

Also Published As

Publication number	Publication date
WO2009007426A1 (en)	2009-01-15
US8445457B2 (en)	2013-05-21
MA31507B1 (fr)	2010-07-01
TN2010000008A1 (en)	2011-09-26
PE20130180A1 (es)	2013-03-06
RU2493826C2 (ru)	2013-09-27
US20100197629A1 (en)	2010-08-05
ECSP109871A (es)	2010-02-26
JP5314014B2 (ja)	2013-10-16
CO6270204A2 (es)	2011-04-20
MY147366A (en)	2012-11-30
TW200911302A (en)	2009-03-16
KR20120078754A (ko)	2012-07-10
PE20090476A1 (es)	2009-05-12
AU2008274170A1 (en)	2009-01-15
CN101686938B (zh)	2012-09-05
IL202961A (en)	2013-10-31
EP2178503A1 (en)	2010-04-28
CL2008002025A1 (es)	2009-05-08
CA2693609A1 (en)	2009-01-15
CN101686938A (zh)	2010-03-31
KR20140019040A (ko)	2014-02-13
AU2008274170B2 (en)	2011-06-09
ZA200908993B (en)	2010-09-29
JP2010533146A (ja)	2010-10-21
AR067630A1 (es)	2009-10-21
RU2010104395A (ru)	2011-08-20
KR20100029829A (ko)	2010-03-17
NZ582443A (en)	2011-04-29

Publication	Publication Date	Title
BRPI0808889A2 (pt)	2014-11-11	Comprimido desintegrante oral
BRPI0820997A2 (pt)	2014-12-23	Comprimidos de desintegração oral compreendendo difenidramina.
BRPI0810646A2 (pt)	2014-11-04	" compostos farmacêuticos ".
EP1992348A4 (en)	2009-09-23	PHARMACEUTICAL COMBINATION
BRPI0817927A2 (pt)	2015-04-07	Comprimidos orodispersiveis
DK2343071T3 (da)	2013-05-13	Farmaceutiske doseringsformer
BRPI0820861A2 (pt)	2015-06-16	Comprimido oral dispersível
ATE532788T1 (de)	2011-11-15	Pharmazeutische verbindungen
BRPI0820381A2 (pt)	2015-05-19	Formulações farmacêuticas
HRP20250383T3 (hr)	2025-07-18	Tablete koje sadrže eltrombopag olamin
DK2077729T3 (da)	2014-07-28	Orale probiotiske doseringsformer
DK1907037T3 (da)	2019-10-21	Medikamentdispenser.
DK2139494T3 (da)	2020-05-25	Farmaceutiske formuleringer, der indeholder dapagliflozin-propylenglycolhydrat
PL2086458T3 (pl)	2017-01-31	System do higieny jamy ustnej
BRPI0715712A2 (pt)	2014-06-24	Composição farmacêutica
DK2151438T3 (da)	2012-11-26	Lægemiddel indeholdende PPAR-Deltaagonist
BRPI0719393A2 (pt)	2015-03-31	Composição farmacêutica
DK1957073T3 (da)	2014-05-12	Lægemiddel
BRPI0813245A2 (pt)	2014-12-23	Escova de dentes.
ATE493119T1 (de)	2011-01-15	Pharmazeutische zusammensetzung
EP2246052A4 (en)	2013-10-16	RASCH IN THE MOUTH DAMAGING TABLET WITH IMIDAFENACIN
BRPI0716445A2 (pt)	2013-09-17	composiÇço farmacÊutica
BRPI0812916A2 (pt)	2014-12-09	Chupeta
EP2193795A4 (en)	2013-09-18	AQUEOUS PHARMACEUTICAL COMPOSITION CONTAINING LATANOPROST
BRPI0812964A2 (pt)	2014-12-16	Forma de dosagem farmacêutica oral sólida

Legal Events

Date	Code	Title	Description
2016-09-20	B08F	Application fees: application dismissed [chapter 8.6 patent gazette]	Free format text: REFERENTE A 8A ANUIDADE.
2017-01-10	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.